JPS6139947B2 - - Google Patents
Info
- Publication number
- JPS6139947B2 JPS6139947B2 JP52014335A JP1433577A JPS6139947B2 JP S6139947 B2 JPS6139947 B2 JP S6139947B2 JP 52014335 A JP52014335 A JP 52014335A JP 1433577 A JP1433577 A JP 1433577A JP S6139947 B2 JPS6139947 B2 JP S6139947B2
- Authority
- JP
- Japan
- Prior art keywords
- pyrimidine
- dihydro
- oxo
- melting point
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 150000001875 compounds Chemical class 0.000 claims description 133
- -1 cyclopropylalkyloxy Chemical group 0.000 claims description 104
- 238000000034 method Methods 0.000 claims description 89
- 238000004519 manufacturing process Methods 0.000 claims description 58
- 238000010992 reflux Methods 0.000 claims description 40
- 150000003839 salts Chemical class 0.000 claims description 39
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 36
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 claims description 34
- 125000003545 alkoxy group Chemical group 0.000 claims description 26
- 239000002904 solvent Substances 0.000 claims description 26
- 238000006243 chemical reaction Methods 0.000 claims description 22
- 229910052739 hydrogen Inorganic materials 0.000 claims description 22
- 239000001257 hydrogen Substances 0.000 claims description 22
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 claims description 20
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 16
- 125000003282 alkyl amino group Chemical group 0.000 claims description 15
- 125000003342 alkenyl group Chemical group 0.000 claims description 12
- 150000002431 hydrogen Chemical class 0.000 claims description 11
- 235000019270 ammonium chloride Nutrition 0.000 claims description 10
- 239000003960 organic solvent Substances 0.000 claims description 10
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 9
- 125000005336 allyloxy group Chemical group 0.000 claims description 9
- KTMGNAIGXYODKQ-UHFFFAOYSA-N ethyl 2-cyano-3-ethoxyprop-2-enoate Chemical compound CCOC=C(C#N)C(=O)OCC KTMGNAIGXYODKQ-UHFFFAOYSA-N 0.000 claims description 7
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 7
- 239000012442 inert solvent Substances 0.000 claims description 6
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 6
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical class NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 claims description 3
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 claims description 3
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 claims description 3
- 159000000000 sodium salts Chemical class 0.000 claims description 3
- 150000002169 ethanolamines Chemical class 0.000 claims 1
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 claims 1
- 125000003506 n-propoxy group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])O* 0.000 claims 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 159
- 238000002844 melting Methods 0.000 description 130
- 230000008018 melting Effects 0.000 description 130
- 239000000203 mixture Substances 0.000 description 119
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 93
- 239000000243 solution Substances 0.000 description 71
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 66
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 63
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 54
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 54
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 45
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 39
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 37
- 238000003756 stirring Methods 0.000 description 36
- 239000007787 solid Substances 0.000 description 33
- 239000005457 ice water Substances 0.000 description 32
- 239000007788 liquid Substances 0.000 description 31
- 229960000583 acetic acid Drugs 0.000 description 27
- 239000002244 precipitate Substances 0.000 description 26
- 238000002360 preparation method Methods 0.000 description 26
- 239000000047 product Substances 0.000 description 26
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 24
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 22
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 20
- 230000008569 process Effects 0.000 description 20
- LTMHNWPUDSTBKD-UHFFFAOYSA-N diethyl 2-(ethoxymethylidene)propanedioate Chemical compound CCOC=C(C(=O)OCC)C(=O)OCC LTMHNWPUDSTBKD-UHFFFAOYSA-N 0.000 description 19
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- 239000012362 glacial acetic acid Substances 0.000 description 15
- 239000002253 acid Substances 0.000 description 14
- 239000011734 sodium Substances 0.000 description 14
- 241001465754 Metazoa Species 0.000 description 13
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 13
- 239000000725 suspension Substances 0.000 description 13
- 238000012360 testing method Methods 0.000 description 13
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 12
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 12
- 235000011054 acetic acid Nutrition 0.000 description 12
- 229910021529 ammonia Inorganic materials 0.000 description 12
- 238000004458 analytical method Methods 0.000 description 12
- 239000000427 antigen Substances 0.000 description 12
- 102000036639 antigens Human genes 0.000 description 12
- 108091007433 antigens Proteins 0.000 description 12
- PXXJHWLDUBFPOL-UHFFFAOYSA-N benzamidine Chemical compound NC(=N)C1=CC=CC=C1 PXXJHWLDUBFPOL-UHFFFAOYSA-N 0.000 description 12
- 229910052708 sodium Inorganic materials 0.000 description 12
- 125000001424 substituent group Chemical group 0.000 description 12
- 238000000354 decomposition reaction Methods 0.000 description 11
- 238000010790 dilution Methods 0.000 description 11
- 239000012895 dilution Substances 0.000 description 11
- 238000001953 recrystallisation Methods 0.000 description 11
- 230000002829 reductive effect Effects 0.000 description 11
- 210000002966 serum Anatomy 0.000 description 11
- 150000003937 benzamidines Chemical class 0.000 description 10
- 239000003814 drug Substances 0.000 description 10
- 229910000027 potassium carbonate Inorganic materials 0.000 description 10
- 239000007858 starting material Substances 0.000 description 10
- LZCZIHQBSCVGRD-UHFFFAOYSA-N benzenecarboximidamide;hydron;chloride Chemical compound [Cl-].NC(=[NH2+])C1=CC=CC=C1 LZCZIHQBSCVGRD-UHFFFAOYSA-N 0.000 description 9
- SBNKFTQSBPKMBZ-UHFFFAOYSA-N ethenzamide Chemical compound CCOC1=CC=CC=C1C(N)=O SBNKFTQSBPKMBZ-UHFFFAOYSA-N 0.000 description 9
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 9
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 9
- 239000000543 intermediate Substances 0.000 description 9
- QDXGKRWDQCEABB-UHFFFAOYSA-N pyrimidine-5-carboxamide Chemical compound NC(=O)C1=CN=CN=C1 QDXGKRWDQCEABB-UHFFFAOYSA-N 0.000 description 9
- 239000011541 reaction mixture Substances 0.000 description 9
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 8
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 8
- MJBWDEQAUQTVKK-IAGOWNOFSA-N aflatoxin M1 Chemical compound C=1([C@]2(O)C=CO[C@@H]2OC=1C=C(C1=2)OC)C=2OC(=O)C2=C1CCC2=O MJBWDEQAUQTVKK-IAGOWNOFSA-N 0.000 description 8
- 238000007429 general method Methods 0.000 description 8
- 238000010438 heat treatment Methods 0.000 description 8
- 150000002825 nitriles Chemical class 0.000 description 8
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 8
- 235000011181 potassium carbonates Nutrition 0.000 description 8
- 229910052938 sodium sulfate Inorganic materials 0.000 description 8
- 235000011152 sodium sulphate Nutrition 0.000 description 8
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 7
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 7
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 7
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 7
- 229910052783 alkali metal Inorganic materials 0.000 description 7
- 239000002585 base Substances 0.000 description 7
- 239000003795 chemical substances by application Substances 0.000 description 7
- 229940079593 drug Drugs 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- 241000699666 Mus <mouse, genus> Species 0.000 description 6
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 6
- 208000006673 asthma Diseases 0.000 description 6
- NHBDYNVEEOSTIH-UHFFFAOYSA-N chembl14922 Chemical compound CCCOC1=CC=CC=C1C(NC1=O)=NC=C1C1=NN=NN1 NHBDYNVEEOSTIH-UHFFFAOYSA-N 0.000 description 6
- 238000004821 distillation Methods 0.000 description 6
- 150000002148 esters Chemical class 0.000 description 6
- 239000000499 gel Substances 0.000 description 6
- AHRQYOSAXZQCIG-UHFFFAOYSA-N pyrimidine-5-carbonitrile Chemical compound N#CC1=C=NC=N[CH]1 AHRQYOSAXZQCIG-UHFFFAOYSA-N 0.000 description 6
- 229920006395 saturated elastomer Polymers 0.000 description 6
- 239000002002 slurry Substances 0.000 description 6
- 239000011780 sodium chloride Substances 0.000 description 6
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 6
- NGMHLSBQVIXGNZ-UHFFFAOYSA-N (2-ethoxybenzenecarboximidoyl)azanium;chloride Chemical compound Cl.CCOC1=CC=CC=C1C(N)=N NGMHLSBQVIXGNZ-UHFFFAOYSA-N 0.000 description 5
- DNCYBUMDUBHIJZ-UHFFFAOYSA-N 1h-pyrimidin-6-one Chemical class O=C1C=CN=CN1 DNCYBUMDUBHIJZ-UHFFFAOYSA-N 0.000 description 5
- ARRHAFFWXFQZSR-UHFFFAOYSA-N 2-(2-ethoxyphenyl)-6-oxo-1h-pyrimidine-5-carbonitrile Chemical compound CCOC1=CC=CC=C1C1=NC=C(C#N)C(=O)N1 ARRHAFFWXFQZSR-UHFFFAOYSA-N 0.000 description 5
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 5
- 241000699670 Mus sp. Species 0.000 description 5
- 108010058846 Ovalbumin Proteins 0.000 description 5
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 5
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 5
- 239000000908 ammonium hydroxide Substances 0.000 description 5
- 238000009833 condensation Methods 0.000 description 5
- 230000005494 condensation Effects 0.000 description 5
- 238000006482 condensation reaction Methods 0.000 description 5
- NTOYIGNATVNWOU-UHFFFAOYSA-N ethyl 2-(2-ethoxyphenyl)-6-oxo-1h-pyrimidine-5-carboxylate Chemical compound N1C(=O)C(C(=O)OCC)=CN=C1C1=CC=CC=C1OCC NTOYIGNATVNWOU-UHFFFAOYSA-N 0.000 description 5
- 239000000284 extract Substances 0.000 description 5
- 239000012458 free base Substances 0.000 description 5
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 5
- 239000008194 pharmaceutical composition Substances 0.000 description 5
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 5
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 5
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 4
- HNTRYPFDBNXKOS-UHFFFAOYSA-N 2-(2-methylpropoxy)benzenecarboximidamide Chemical compound CC(C)COC1=CC=CC=C1C(N)=N HNTRYPFDBNXKOS-UHFFFAOYSA-N 0.000 description 4
- NWELOPILLFFSFZ-UHFFFAOYSA-N 2-(cyclopropylmethoxy)benzenecarboximidamide;hydrochloride Chemical compound Cl.NC(=N)C1=CC=CC=C1OCC1CC1 NWELOPILLFFSFZ-UHFFFAOYSA-N 0.000 description 4
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 4
- OIEYSUXLJYFFPI-UHFFFAOYSA-N 2-ethoxybenzenecarboximidamide;sulfurofluoridic acid Chemical compound OS(F)(=O)=O.CCOC1=CC=CC=C1C(N)=N OIEYSUXLJYFFPI-UHFFFAOYSA-N 0.000 description 4
- KNOPIPOLVBCPEN-UHFFFAOYSA-N 2-ethylsulfanylbenzenecarboximidamide;hydrochloride Chemical compound Cl.CCSC1=CC=CC=C1C(N)=N KNOPIPOLVBCPEN-UHFFFAOYSA-N 0.000 description 4
- JQCXHLMDSPVRLE-UHFFFAOYSA-N 5-methoxy-2-propoxybenzenecarboximidamide;hydrochloride Chemical compound Cl.CCCOC1=CC=C(OC)C=C1C(N)=N JQCXHLMDSPVRLE-UHFFFAOYSA-N 0.000 description 4
- KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical compound NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 description 4
- RZZPDXZPRHQOCG-OJAKKHQRSA-O CDP-choline(1+) Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OCC[N+](C)(C)C)O[C@H]1N1C(=O)N=C(N)C=C1 RZZPDXZPRHQOCG-OJAKKHQRSA-O 0.000 description 4
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 4
- 206010020751 Hypersensitivity Diseases 0.000 description 4
- 229910000831 Steel Inorganic materials 0.000 description 4
- 241000700647 Variola virus Species 0.000 description 4
- XZHKVYYQQVEUBZ-UHFFFAOYSA-N [amino-(2-propoxyphenyl)methylidene]azanium;chloride Chemical compound Cl.CCCOC1=CC=CC=C1C(N)=N XZHKVYYQQVEUBZ-UHFFFAOYSA-N 0.000 description 4
- 150000007513 acids Chemical class 0.000 description 4
- 239000000538 analytical sample Substances 0.000 description 4
- 239000001045 blue dye Substances 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- VLARUOGDXDTHEH-UHFFFAOYSA-L disodium cromoglycate Chemical compound [Na+].[Na+].O1C(C([O-])=O)=CC(=O)C2=C1C=CC=C2OCC(O)COC1=CC=CC2=C1C(=O)C=C(C([O-])=O)O2 VLARUOGDXDTHEH-UHFFFAOYSA-L 0.000 description 4
- IVBFHLYXRBKTMG-UHFFFAOYSA-N ethyl 6-oxo-2-(2-propoxyphenyl)-1h-pyrimidine-5-carboxylate Chemical compound CCCOC1=CC=CC=C1C1=NC=C(C(=O)OCC)C(=O)N1 IVBFHLYXRBKTMG-UHFFFAOYSA-N 0.000 description 4
- 230000003053 immunization Effects 0.000 description 4
- 238000002649 immunization Methods 0.000 description 4
- MBXNQZHITVCSLJ-UHFFFAOYSA-N methyl fluorosulfonate Chemical compound COS(F)(=O)=O MBXNQZHITVCSLJ-UHFFFAOYSA-N 0.000 description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 4
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical compound CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 4
- 239000000376 reactant Substances 0.000 description 4
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 4
- 235000017557 sodium bicarbonate Nutrition 0.000 description 4
- 239000010959 steel Substances 0.000 description 4
- YNJQOVDUKUWUQT-UHFFFAOYSA-N 2-butoxybenzenecarboximidamide;hydrochloride Chemical compound Cl.CCCCOC1=CC=CC=C1C(N)=N YNJQOVDUKUWUQT-UHFFFAOYSA-N 0.000 description 3
- JNYOMPUIZRNERF-UHFFFAOYSA-N 2-ethoxy-5-methoxybenzenecarboximidamide;hydrochloride Chemical compound Cl.CCOC1=CC=C(OC)C=C1C(N)=N JNYOMPUIZRNERF-UHFFFAOYSA-N 0.000 description 3
- GOSDGLKRVHPJEV-UHFFFAOYSA-N 2-ethoxybenzenecarboximidamide Chemical compound CCOC1=CC=CC=C1C(N)=N GOSDGLKRVHPJEV-UHFFFAOYSA-N 0.000 description 3
- IOJAQFYHZXUYDH-UHFFFAOYSA-N 2-propan-2-yloxybenzenecarboximidamide;hydrochloride Chemical compound Cl.CC(C)OC1=CC=CC=C1C(N)=N IOJAQFYHZXUYDH-UHFFFAOYSA-N 0.000 description 3
- COXVTLYNGOIATD-HVMBLDELSA-N CC1=C(C=CC(=C1)C1=CC(C)=C(C=C1)\N=N\C1=C(O)C2=C(N)C(=CC(=C2C=C1)S(O)(=O)=O)S(O)(=O)=O)\N=N\C1=CC=C2C(=CC(=C(N)C2=C1O)S(O)(=O)=O)S(O)(=O)=O Chemical compound CC1=C(C=CC(=C1)C1=CC(C)=C(C=C1)\N=N\C1=C(O)C2=C(N)C(=CC(=C2C=C1)S(O)(=O)=O)S(O)(=O)=O)\N=N\C1=CC=C2C(=CC(=C(N)C2=C1O)S(O)(=O)=O)S(O)(=O)=O COXVTLYNGOIATD-HVMBLDELSA-N 0.000 description 3
- SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 description 3
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- 206010070834 Sensitisation Diseases 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 239000012267 brine Substances 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 150000003857 carboxamides Chemical class 0.000 description 3
- 150000007942 carboxylates Chemical class 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 235000008504 concentrate Nutrition 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- NPOMSUOUAZCMBL-UHFFFAOYSA-N dichloromethane;ethoxyethane Chemical compound ClCCl.CCOCC NPOMSUOUAZCMBL-UHFFFAOYSA-N 0.000 description 3
- VAYGXNSJCAHWJZ-UHFFFAOYSA-N dimethyl sulfate Chemical compound COS(=O)(=O)OC VAYGXNSJCAHWJZ-UHFFFAOYSA-N 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- KHLKWMAHIJEMOS-UHFFFAOYSA-N ethyl 2-[2-(2-methylpropoxy)phenyl]-6-oxo-1h-pyrimidine-5-carboxylate Chemical compound N1C(=O)C(C(=O)OCC)=CN=C1C1=CC=CC=C1OCC(C)C KHLKWMAHIJEMOS-UHFFFAOYSA-N 0.000 description 3
- JSIHCFJCICVJHJ-UHFFFAOYSA-N ethyl 6-oxo-2-phenyl-1h-pyrimidine-5-carboxylate Chemical class N1C(=O)C(C(=O)OCC)=CN=C1C1=CC=CC=C1 JSIHCFJCICVJHJ-UHFFFAOYSA-N 0.000 description 3
- 229960003699 evans blue Drugs 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- HVTICUPFWKNHNG-UHFFFAOYSA-N iodoethane Chemical compound CCI HVTICUPFWKNHNG-UHFFFAOYSA-N 0.000 description 3
- PCIWGHJCGMRZDJ-UHFFFAOYSA-N methyl hydrogen sulfate;2-propoxybenzenecarboximidamide Chemical compound COS(O)(=O)=O.CCCOC1=CC=CC=C1C(N)=N PCIWGHJCGMRZDJ-UHFFFAOYSA-N 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 229910017604 nitric acid Inorganic materials 0.000 description 3
- 239000012053 oil suspension Substances 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 125000005920 sec-butoxy group Chemical group 0.000 description 3
- 230000008313 sensitization Effects 0.000 description 3
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 235000020357 syrup Nutrition 0.000 description 3
- 239000006188 syrup Substances 0.000 description 3
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 3
- 239000003656 tris buffered saline Substances 0.000 description 3
- 125000000027 (C1-C10) alkoxy group Chemical group 0.000 description 2
- SBZSBHNPMBQOJQ-UHFFFAOYSA-N 2-(2-methoxyphenyl)-6-oxo-1h-pyrimidine-5-carbonitrile Chemical compound COC1=CC=CC=C1C1=NC=C(C#N)C(=O)N1 SBZSBHNPMBQOJQ-UHFFFAOYSA-N 0.000 description 2
- FVPWCKBAQIZSFS-UHFFFAOYSA-N 2-(2-methylpropoxy)benzamide Chemical compound CC(C)COC1=CC=CC=C1C(N)=O FVPWCKBAQIZSFS-UHFFFAOYSA-N 0.000 description 2
- HCKPJFSKECFIMT-UHFFFAOYSA-N 2-(2-methylpropoxy)benzenecarboximidamide;sulfurofluoridic acid Chemical compound OS(F)(=O)=O.CC(C)COC1=CC=CC=C1C(N)=N HCKPJFSKECFIMT-UHFFFAOYSA-N 0.000 description 2
- DYKSYOILKQVOHZ-UHFFFAOYSA-N 2-(5-methoxy-2-propoxyphenyl)-6-oxo-1h-pyrimidine-5-carbonitrile Chemical compound CCCOC1=CC=C(OC)C=C1C1=NC=C(C#N)C(=O)N1 DYKSYOILKQVOHZ-UHFFFAOYSA-N 0.000 description 2
- YGSJZZHYXOPQFQ-UHFFFAOYSA-N 2-(cyclopropylmethoxy)benzamide Chemical compound NC(=O)C1=CC=CC=C1OCC1CC1 YGSJZZHYXOPQFQ-UHFFFAOYSA-N 0.000 description 2
- NDBMNHFFDSSFHG-UHFFFAOYSA-N 2-butan-2-yloxybenzenecarboximidamide;hydrochloride Chemical compound Cl.CCC(C)OC1=CC=CC=C1C(N)=N NDBMNHFFDSSFHG-UHFFFAOYSA-N 0.000 description 2
- VPTQXJGFCHOGAN-UHFFFAOYSA-N 2-butoxybenzamide Chemical compound CCCCOC1=CC=CC=C1C(N)=O VPTQXJGFCHOGAN-UHFFFAOYSA-N 0.000 description 2
- BAFPIVSUZRAYKE-UHFFFAOYSA-N 2-ethoxy-5-methoxybenzamide Chemical compound CCOC1=CC=C(OC)C=C1C(N)=O BAFPIVSUZRAYKE-UHFFFAOYSA-N 0.000 description 2
- VLSVEVCSHFHKEM-UHFFFAOYSA-N 2-hydroxy-5-methoxybenzamide Chemical compound COC1=CC=C(O)C(C(N)=O)=C1 VLSVEVCSHFHKEM-UHFFFAOYSA-N 0.000 description 2
- BTHLVVULQLRTBK-UHFFFAOYSA-N 2-propan-2-yloxybenzamide Chemical compound CC(C)OC1=CC=CC=C1C(N)=O BTHLVVULQLRTBK-UHFFFAOYSA-N 0.000 description 2
- UXVZNLSQKHVKBJ-UHFFFAOYSA-N 2-propan-2-yloxybenzenecarboximidamide Chemical compound CC(C)OC1=CC=CC=C1C(N)=N UXVZNLSQKHVKBJ-UHFFFAOYSA-N 0.000 description 2
- FAVIQMSTEFBUJX-UHFFFAOYSA-N 2-propoxybenzamide Chemical compound CCCOC1=CC=CC=C1C(N)=O FAVIQMSTEFBUJX-UHFFFAOYSA-N 0.000 description 2
- CLXPJHFVNFNTAR-UHFFFAOYSA-N 2-propoxybenzenecarboximidamide Chemical compound CCCOC1=CC=CC=C1C(N)=N CLXPJHFVNFNTAR-UHFFFAOYSA-N 0.000 description 2
- 125000000590 4-methylphenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 description 2
- AEDNEIUPKSLIDZ-UHFFFAOYSA-N 5-(2H-tetrazol-5-yl)-1H-pyrimidin-6-one Chemical class O=C1NC=NC=C1C1=NN=NN1 AEDNEIUPKSLIDZ-UHFFFAOYSA-N 0.000 description 2
- PKHNMHLTBWZQCA-UHFFFAOYSA-N 5-chloro-2-ethoxybenzenecarboximidamide;hydrochloride Chemical compound Cl.CCOC1=CC=C(Cl)C=C1C(N)=N PKHNMHLTBWZQCA-UHFFFAOYSA-N 0.000 description 2
- GNFNHGDLBKMDQF-UHFFFAOYSA-N 6-oxo-2-(2-propoxyphenyl)-1h-pyrimidine-5-carboxamide Chemical compound CCCOC1=CC=CC=C1C1=NC=C(C(N)=O)C(=O)N1 GNFNHGDLBKMDQF-UHFFFAOYSA-N 0.000 description 2
- 229910018626 Al(OH) Inorganic materials 0.000 description 2
- 206010002198 Anaphylactic reaction Diseases 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- LELOWRISYMNNSU-UHFFFAOYSA-N Hydrocyanic acid Natural products N#C LELOWRISYMNNSU-UHFFFAOYSA-N 0.000 description 2
- WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 206010039085 Rhinitis allergic Diseases 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 239000000443 aerosol Substances 0.000 description 2
- 150000001340 alkali metals Chemical class 0.000 description 2
- 208000026935 allergic disease Diseases 0.000 description 2
- 230000000172 allergic effect Effects 0.000 description 2
- 201000010105 allergic rhinitis Diseases 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 230000036783 anaphylactic response Effects 0.000 description 2
- 208000003455 anaphylaxis Diseases 0.000 description 2
- 239000000043 antiallergic agent Substances 0.000 description 2
- 239000007900 aqueous suspension Substances 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 150000001540 azides Chemical class 0.000 description 2
- WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- HQABUPZFAYXKJW-UHFFFAOYSA-N butan-1-amine Chemical compound CCCCN HQABUPZFAYXKJW-UHFFFAOYSA-N 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 229960000265 cromoglicic acid Drugs 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- 125000004093 cyano group Chemical group *C#N 0.000 description 2
- PAFZNILMFXTMIY-UHFFFAOYSA-N cyclohexylamine Chemical compound NC1CCCCC1 PAFZNILMFXTMIY-UHFFFAOYSA-N 0.000 description 2
- 239000003937 drug carrier Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- NXRODQNBHNHXBY-UHFFFAOYSA-N ethyl 2-[2-(cyclopropylmethoxy)phenyl]-6-oxo-1h-pyrimidine-5-carboxylate Chemical compound N1C(=O)C(C(=O)OCC)=CN=C1C1=CC=CC=C1OCC1CC1 NXRODQNBHNHXBY-UHFFFAOYSA-N 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 230000002163 immunogen Effects 0.000 description 2
- 238000011065 in-situ storage Methods 0.000 description 2
- 239000007927 intramuscular injection Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 229910052751 metal Chemical class 0.000 description 2
- 239000002184 metal Chemical class 0.000 description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 2
- NSNDIPJPWIDPBY-UHFFFAOYSA-N methyl 3-carbamoyl-4-ethoxybenzoate Chemical compound CCOC1=CC=C(C(=O)OC)C=C1C(N)=O NSNDIPJPWIDPBY-UHFFFAOYSA-N 0.000 description 2
- JZMJDSHXVKJFKW-UHFFFAOYSA-M methyl sulfate(1-) Chemical compound COS([O-])(=O)=O JZMJDSHXVKJFKW-UHFFFAOYSA-M 0.000 description 2
- 229910000069 nitrogen hydride Inorganic materials 0.000 description 2
- 230000020477 pH reduction Effects 0.000 description 2
- WEXRUCMBJFQVBZ-UHFFFAOYSA-N pentobarbital Chemical compound CCCC(C)C1(CC)C(=O)NC(=O)NC1=O WEXRUCMBJFQVBZ-UHFFFAOYSA-N 0.000 description 2
- 239000008024 pharmaceutical diluent Substances 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 235000015320 potassium carbonate Nutrition 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 235000010356 sorbitol Nutrition 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 150000003536 tetrazoles Chemical class 0.000 description 2
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 2
- 229940124597 therapeutic agent Drugs 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- DWCSXQCXXITVKE-UHFFFAOYSA-N triethyloxidanium Chemical compound CC[O+](CC)CC DWCSXQCXXITVKE-UHFFFAOYSA-N 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- JWZZKOKVBUJMES-UHFFFAOYSA-N (+-)-Isoprenaline Chemical compound CC(C)NCC(O)C1=CC=C(O)C(O)=C1 JWZZKOKVBUJMES-UHFFFAOYSA-N 0.000 description 1
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 1
- 229930182837 (R)-adrenaline Natural products 0.000 description 1
- SGUVLZREKBPKCE-UHFFFAOYSA-N 1,5-diazabicyclo[4.3.0]-non-5-ene Chemical compound C1CCN=C2CCCN21 SGUVLZREKBPKCE-UHFFFAOYSA-N 0.000 description 1
- CYNYIHKIEHGYOZ-UHFFFAOYSA-N 1-bromopropane Chemical compound CCCBr CYNYIHKIEHGYOZ-UHFFFAOYSA-N 0.000 description 1
- OVOJUAKDTOOXRF-UHFFFAOYSA-N 2,4-dinitrobenzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=C([N+]([O-])=O)C=C1[N+]([O-])=O OVOJUAKDTOOXRF-UHFFFAOYSA-N 0.000 description 1
- KLYZILOJVQMYSK-UHFFFAOYSA-N 2,5-dimethoxybenzamide Chemical compound COC1=CC=C(OC)C(C(N)=O)=C1 KLYZILOJVQMYSK-UHFFFAOYSA-N 0.000 description 1
- MLVYVEAUXWOKLK-UHFFFAOYSA-N 2,5-dimethoxybenzenecarboximidamide;hydrochloride Chemical group Cl.COC1=CC=C(OC)C(C(N)=N)=C1 MLVYVEAUXWOKLK-UHFFFAOYSA-N 0.000 description 1
- ICFDGFXITVNHRK-UHFFFAOYSA-N 2-(2,4-dimethoxyphenyl)-6-oxo-1h-pyrimidine-5-carbonitrile Chemical compound COC1=CC(OC)=CC=C1C1=NC=C(C#N)C(=O)N1 ICFDGFXITVNHRK-UHFFFAOYSA-N 0.000 description 1
- PQNUTUVCLMTPQH-UHFFFAOYSA-N 2-(2,4-dimethoxyphenyl)-6-oxo-1h-pyrimidine-5-carboxamide Chemical compound COC1=CC(OC)=CC=C1C1=NC=C(C(N)=O)C(=O)N1 PQNUTUVCLMTPQH-UHFFFAOYSA-N 0.000 description 1
- QVPVUXUNYUXCRY-UHFFFAOYSA-N 2-(2-aminophenyl)-6-oxo-1h-pyrimidine-5-carbonitrile Chemical compound NC1=CC=CC=C1C1=NC=C(C#N)C(=O)N1 QVPVUXUNYUXCRY-UHFFFAOYSA-N 0.000 description 1
- UACKEROANJJXAG-UHFFFAOYSA-N 2-(2-butan-2-yloxyphenyl)-6-oxo-1h-pyrimidine-5-carbonitrile Chemical compound CCC(C)OC1=CC=CC=C1C1=NC=C(C#N)C(=O)N1 UACKEROANJJXAG-UHFFFAOYSA-N 0.000 description 1
- NTSMEITWGNDZDR-UHFFFAOYSA-N 2-(2-butoxyphenyl)-6-oxo-1h-pyrimidine-5-carbonitrile Chemical compound CCCCOC1=CC=CC=C1C1=NC=C(C#N)C(=O)N1 NTSMEITWGNDZDR-UHFFFAOYSA-N 0.000 description 1
- PKJFISRTTMCBTP-UHFFFAOYSA-N 2-(2-butoxyphenyl)-6-oxo-1h-pyrimidine-5-carboxamide Chemical compound CCCCOC1=CC=CC=C1C1=NC=C(C(N)=O)C(=O)N1 PKJFISRTTMCBTP-UHFFFAOYSA-N 0.000 description 1
- FRBBHRIEGGPXPK-UHFFFAOYSA-N 2-(2-butoxyphenyl)-6-oxo-1h-pyrimidine-5-carboxylic acid Chemical compound CCCCOC1=CC=CC=C1C1=NC=C(C(O)=O)C(=O)N1 FRBBHRIEGGPXPK-UHFFFAOYSA-N 0.000 description 1
- DIOIUBFOJHVCEV-UHFFFAOYSA-N 2-(2-chlorophenyl)-6-oxo-1h-pyrimidine-5-carbonitrile Chemical compound ClC1=CC=CC=C1C1=NC=C(C#N)C(=O)N1 DIOIUBFOJHVCEV-UHFFFAOYSA-N 0.000 description 1
- ARWIMWVZVXLKBU-UHFFFAOYSA-N 2-(2-ethoxyphenyl)-6-oxo-1h-pyrimidine-5-carboxamide Chemical compound CCOC1=CC=CC=C1C1=NC=C(C(N)=O)C(=O)N1 ARWIMWVZVXLKBU-UHFFFAOYSA-N 0.000 description 1
- VGVQEYGZRWWMEH-UHFFFAOYSA-N 2-(2-ethylsulfanylphenyl)-6-oxo-1h-pyrimidine-5-carbonitrile Chemical compound CCSC1=CC=CC=C1C1=NC=C(C#N)C(=O)N1 VGVQEYGZRWWMEH-UHFFFAOYSA-N 0.000 description 1
- UVLLANBQRSNMCR-UHFFFAOYSA-N 2-(2-ethylsulfanylphenyl)-6-oxo-1h-pyrimidine-5-carboxamide Chemical compound CCSC1=CC=CC=C1C1=NC=C(C(N)=O)C(=O)N1 UVLLANBQRSNMCR-UHFFFAOYSA-N 0.000 description 1
- JDMAVDMBAAYFMV-UHFFFAOYSA-N 2-(2-fluorophenyl)-6-oxo-1h-pyrimidine-5-carbonitrile Chemical compound FC1=CC=CC=C1C1=NC=C(C#N)C(=O)N1 JDMAVDMBAAYFMV-UHFFFAOYSA-N 0.000 description 1
- XOPOHPLMVKGNRP-UHFFFAOYSA-N 2-(2-fluorophenyl)-6-oxo-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)C(C(=O)N)=CN=C1C1=CC=CC=C1F XOPOHPLMVKGNRP-UHFFFAOYSA-N 0.000 description 1
- FRZAQRDCKJUPJS-UHFFFAOYSA-N 2-(2-methoxyphenyl)-6-oxo-1h-pyrimidine-5-carboxamide Chemical compound COC1=CC=CC=C1C1=NC=C(C(N)=O)C(=O)N1 FRZAQRDCKJUPJS-UHFFFAOYSA-N 0.000 description 1
- QGKKTMWKXYUJPL-UHFFFAOYSA-N 2-(2-methylsulfanylphenyl)-6-oxo-1h-pyrimidine-5-carbonitrile Chemical compound CSC1=CC=CC=C1C1=NC=C(C#N)C(=O)N1 QGKKTMWKXYUJPL-UHFFFAOYSA-N 0.000 description 1
- UCJIBPIIGMHSJL-UHFFFAOYSA-N 2-(2-methylsulfanylphenyl)-6-oxo-1h-pyrimidine-5-carboxamide Chemical compound CSC1=CC=CC=C1C1=NC=C(C(N)=O)C(=O)N1 UCJIBPIIGMHSJL-UHFFFAOYSA-N 0.000 description 1
- GCSGRYMRVIGNHY-UHFFFAOYSA-N 2-(3-methoxyphenyl)-6-oxo-1h-pyrimidine-5-carbonitrile Chemical compound COC1=CC=CC(C=2NC(=O)C(C#N)=CN=2)=C1 GCSGRYMRVIGNHY-UHFFFAOYSA-N 0.000 description 1
- VZTOOJUQAYRCOP-UHFFFAOYSA-N 2-(3-methoxyphenyl)-6-oxo-1h-pyrimidine-5-carboxamide Chemical compound COC1=CC=CC(C=2NC(=O)C(C(N)=O)=CN=2)=C1 VZTOOJUQAYRCOP-UHFFFAOYSA-N 0.000 description 1
- SGHARSMKWKRMJE-UHFFFAOYSA-N 2-(4-methoxyphenyl)-6-oxo-1h-pyrimidine-5-carbonitrile Chemical compound C1=CC(OC)=CC=C1C1=NC=C(C#N)C(=O)N1 SGHARSMKWKRMJE-UHFFFAOYSA-N 0.000 description 1
- FTPPKHGZSOWGPC-UHFFFAOYSA-N 2-(4-methoxyphenyl)-6-oxo-1h-pyrimidine-5-carboxamide Chemical compound C1=CC(OC)=CC=C1C1=NC=C(C(N)=O)C(=O)N1 FTPPKHGZSOWGPC-UHFFFAOYSA-N 0.000 description 1
- WVJYIBLJGJMIHO-UHFFFAOYSA-N 2-[2-(2-methylpropoxy)phenyl]-6-oxo-1h-pyrimidine-5-carboxamide Chemical compound CC(C)COC1=CC=CC=C1C1=NC=C(C(N)=O)C(=O)N1 WVJYIBLJGJMIHO-UHFFFAOYSA-N 0.000 description 1
- YIJHCIJQRPWMKH-UHFFFAOYSA-N 2-[2-(cyclopropylmethoxy)phenyl]-6-oxo-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)C(C(=O)N)=CN=C1C1=CC=CC=C1OCC1CC1 YIJHCIJQRPWMKH-UHFFFAOYSA-N 0.000 description 1
- JZQLRTAGAUZWRH-UHFFFAOYSA-N 2-aminoethanol;hydrate Chemical compound [OH-].[NH3+]CCO JZQLRTAGAUZWRH-UHFFFAOYSA-N 0.000 description 1
- XWPPEESBKICTHP-UHFFFAOYSA-N 2-butan-2-yloxybenzamide Chemical compound CCC(C)OC1=CC=CC=C1C(N)=O XWPPEESBKICTHP-UHFFFAOYSA-N 0.000 description 1
- DERAACKMMNJAFU-UHFFFAOYSA-N 2-ethoxy-1,3-dioxane-4,6-dione Chemical compound CCOC1OC(=O)CC(=O)O1 DERAACKMMNJAFU-UHFFFAOYSA-N 0.000 description 1
- OEXRGFMNBITBTE-UHFFFAOYSA-N 2-ethoxybenzenecarboximidamide;methyl hydrogen sulfate Chemical compound COS(O)(=O)=O.CCOC1=CC=CC=C1C(N)=N OEXRGFMNBITBTE-UHFFFAOYSA-N 0.000 description 1
- MNWSGMTUGXNYHJ-UHFFFAOYSA-N 2-methoxybenzamide Chemical compound COC1=CC=CC=C1C(N)=O MNWSGMTUGXNYHJ-UHFFFAOYSA-N 0.000 description 1
- IFHHVUXPFHPHBQ-UHFFFAOYSA-N 2-methylsulfanylbenzenecarboximidamide;hydrochloride Chemical compound Cl.CSC1=CC=CC=C1C(N)=N IFHHVUXPFHPHBQ-UHFFFAOYSA-N 0.000 description 1
- AUXXZZHQJXFJTC-UHFFFAOYSA-N 2-nitrobenzenecarboximidamide;hydrochloride Chemical compound Cl.NC(=N)C1=CC=CC=C1[N+]([O-])=O AUXXZZHQJXFJTC-UHFFFAOYSA-N 0.000 description 1
- HNUKTDKISXPDPA-UHFFFAOYSA-N 2-oxopropyl Chemical group [CH2]C(C)=O HNUKTDKISXPDPA-UHFFFAOYSA-N 0.000 description 1
- XGKJSRLZDQBDHT-UHFFFAOYSA-N 2-pentoxybenzenecarboximidamide Chemical compound CCCCCOC1=CC=CC=C1C(N)=N XGKJSRLZDQBDHT-UHFFFAOYSA-N 0.000 description 1
- FSBIAEYLUOBHLG-UHFFFAOYSA-N 2-phenylpyrimidine-5-carboxamide Chemical compound N1=CC(C(=O)N)=CN=C1C1=CC=CC=C1 FSBIAEYLUOBHLG-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- AZEIRPAUJXANCS-UHFFFAOYSA-N 4-ethoxybenzamide Chemical compound CCOC1=CC=C(C(N)=O)C=C1 AZEIRPAUJXANCS-UHFFFAOYSA-N 0.000 description 1
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 description 1
- CVICEEPAFUYBJG-UHFFFAOYSA-N 5-chloro-2,2-difluoro-1,3-benzodioxole Chemical group C1=C(Cl)C=C2OC(F)(F)OC2=C1 CVICEEPAFUYBJG-UHFFFAOYSA-N 0.000 description 1
- VTEHZGVDOYGWFI-UHFFFAOYSA-N 5-methoxy-2-propoxybenzamide Chemical compound CCCOC1=CC=C(OC)C=C1C(N)=O VTEHZGVDOYGWFI-UHFFFAOYSA-N 0.000 description 1
- XZVHBDLWUCTDFI-UHFFFAOYSA-N 6-oxo-2-(2-phenylmethoxyphenyl)-1h-pyrimidine-5-carbonitrile Chemical compound C1=C(C#N)C(=O)NC(C=2C(=CC=CC=2)OCC=2C=CC=CC=2)=N1 XZVHBDLWUCTDFI-UHFFFAOYSA-N 0.000 description 1
- ARGLTJDLEHNYGE-UHFFFAOYSA-N 6-oxo-2-(2-phenylmethoxyphenyl)-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)C(C(=O)N)=CN=C1C1=CC=CC=C1OCC1=CC=CC=C1 ARGLTJDLEHNYGE-UHFFFAOYSA-N 0.000 description 1
- UPDIZRAYBADYSG-UHFFFAOYSA-N 6-oxo-2-(2-propan-2-yloxyphenyl)-1h-pyrimidine-5-carbonitrile Chemical compound CC(C)OC1=CC=CC=C1C1=NC=C(C#N)C(=O)N1 UPDIZRAYBADYSG-UHFFFAOYSA-N 0.000 description 1
- DVOXGRRTZRKEFQ-UHFFFAOYSA-N 6-oxo-2-(2-propoxyphenyl)-1h-pyrimidine-5-carbonitrile Chemical compound CCCOC1=CC=CC=C1C1=NC=C(C#N)C(=O)N1 DVOXGRRTZRKEFQ-UHFFFAOYSA-N 0.000 description 1
- JKHROBFSYBALSG-UHFFFAOYSA-N 6-oxo-2-[3-(trifluoromethyl)phenyl]-1h-pyrimidine-5-carbonitrile Chemical compound FC(F)(F)C1=CC=CC(C=2NC(=O)C(C#N)=CN=2)=C1 JKHROBFSYBALSG-UHFFFAOYSA-N 0.000 description 1
- GPPZJCZWTPPMDD-UHFFFAOYSA-N 6-oxo-2-phenyl-1h-pyrimidine-5-carbonitrile Chemical compound C1=C(C#N)C(=O)NC(C=2C=CC=CC=2)=N1 GPPZJCZWTPPMDD-UHFFFAOYSA-N 0.000 description 1
- HADBIMYTRIMUAO-UHFFFAOYSA-N 6-oxo-2-phenyl-1h-pyrimidine-5-carboxylic acid Chemical class N1C(=O)C(C(=O)O)=CN=C1C1=CC=CC=C1 HADBIMYTRIMUAO-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 229930003347 Atropine Natural products 0.000 description 1
- 241000588807 Bordetella Species 0.000 description 1
- 125000006374 C2-C10 alkenyl group Chemical group 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- UYCVYTWZVMCQCX-UHFFFAOYSA-N ClC1=CC=C(C(C(=O)N)=C1)O.ClC=1C=CC(=C(C(=O)N)C1)OCC Chemical compound ClC1=CC=C(C(C(=O)N)=C1)O.ClC=1C=CC(=C(C(=O)N)C1)OCC UYCVYTWZVMCQCX-UHFFFAOYSA-N 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- NJDOSNDDNPZLGB-UHFFFAOYSA-N FC(C1=CC=C(C=C1)OC(=O)C=1C=NC=NC=1)(F)F Chemical compound FC(C1=CC=C(C=C1)OC(=O)C=1C=NC=NC=1)(F)F NJDOSNDDNPZLGB-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- RKUNBYITZUJHSG-UHFFFAOYSA-N Hyosciamin-hydrochlorid Natural products CN1C(C2)CCC1CC2OC(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
- 240000007472 Leucaena leucocephala Species 0.000 description 1
- 239000002841 Lewis acid Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-L Malonate Chemical compound [O-]C(=O)CC([O-])=O OFOBLEOULBTSOW-UHFFFAOYSA-L 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 229910019440 Mg(OH) Inorganic materials 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- LLNHIGHHDJZQML-UHFFFAOYSA-N O=O.[P] Chemical compound O=O.[P] LLNHIGHHDJZQML-UHFFFAOYSA-N 0.000 description 1
- UKXNYFGZQPXDJA-UHFFFAOYSA-N OC1=C(C(=O)N)C=CC=C1.C1(CC1)COC1=C(C(=O)N)C=CC=C1 Chemical compound OC1=C(C(=O)N)C=CC=C1.C1(CC1)COC1=C(C(=O)N)C=CC=C1 UKXNYFGZQPXDJA-UHFFFAOYSA-N 0.000 description 1
- CWRVKFFCRWGWCS-UHFFFAOYSA-N Pentrazole Chemical compound C1CCCCC2=NN=NN21 CWRVKFFCRWGWCS-UHFFFAOYSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 239000007868 Raney catalyst Substances 0.000 description 1
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 1
- 229910000564 Raney nickel Inorganic materials 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- QDVZTRIRAZTAFG-UHFFFAOYSA-N [Na].CCCOC1=CC=CC=C1C(NC1=O)=NC=C1C1=NN=NN1 Chemical compound [Na].CCCOC1=CC=CC=C1C(NC1=O)=NC=C1C1=NN=NN1 QDVZTRIRAZTAFG-UHFFFAOYSA-N 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- GPEHQHXBPDGGDP-UHFFFAOYSA-N acetonitrile;propan-2-one Chemical compound CC#N.CC(C)=O GPEHQHXBPDGGDP-UHFFFAOYSA-N 0.000 description 1
- 238000007171 acid catalysis Methods 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 229910000288 alkali metal carbonate Inorganic materials 0.000 description 1
- 150000008041 alkali metal carbonates Chemical group 0.000 description 1
- 125000005236 alkanoylamino group Chemical group 0.000 description 1
- 150000004703 alkoxides Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 239000002168 alkylating agent Substances 0.000 description 1
- 229940100198 alkylating agent Drugs 0.000 description 1
- 230000002152 alkylating effect Effects 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 229940024545 aluminum hydroxide Drugs 0.000 description 1
- 229940024546 aluminum hydroxide gel Drugs 0.000 description 1
- YDPLDMLRERBXAV-UHFFFAOYSA-N aluminum;triazide Chemical compound [Al+3].[N-]=[N+]=[N-].[N-]=[N+]=[N-].[N-]=[N+]=[N-] YDPLDMLRERBXAV-UHFFFAOYSA-N 0.000 description 1
- SMYKVLBUSSNXMV-UHFFFAOYSA-K aluminum;trihydroxide;hydrate Chemical compound O.[OH-].[OH-].[OH-].[Al+3] SMYKVLBUSSNXMV-UHFFFAOYSA-K 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000009830 antibody antigen interaction Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- RKUNBYITZUJHSG-SPUOUPEWSA-N atropine Chemical compound O([C@H]1C[C@H]2CC[C@@H](C1)N2C)C(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-SPUOUPEWSA-N 0.000 description 1
- 229960000396 atropine Drugs 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
- VPSOCYILUWQTLX-UHFFFAOYSA-N benzenecarboximidamide;methyl hydrogen sulfate Chemical compound COS(O)(=O)=O.NC(=N)C1=CC=CC=C1 VPSOCYILUWQTLX-UHFFFAOYSA-N 0.000 description 1
- AVXQMQQYGHZGQA-UHFFFAOYSA-N benzenecarboximidamide;sulfurofluoridic acid Chemical compound OS(F)(=O)=O.NC(=N)C1=CC=CC=C1 AVXQMQQYGHZGQA-UHFFFAOYSA-N 0.000 description 1
- KXDAEFPNCMNJSK-UHFFFAOYSA-M benzenecarboximidate Chemical compound [NH-]C(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-M 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- ZADPBFCGQRWHPN-UHFFFAOYSA-N boronic acid Chemical compound OBO ZADPBFCGQRWHPN-UHFFFAOYSA-N 0.000 description 1
- AEILLAXRDHDKDY-UHFFFAOYSA-N bromomethylcyclopropane Chemical compound BrCC1CC1 AEILLAXRDHDKDY-UHFFFAOYSA-N 0.000 description 1
- 229940124630 bronchodilator Drugs 0.000 description 1
- 239000000168 bronchodilator agent Substances 0.000 description 1
- 239000006189 buccal tablet Substances 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 150000001721 carbon Chemical group 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 238000012754 cardiac puncture Methods 0.000 description 1
- ALXDNQNBMITZNJ-UHFFFAOYSA-N chembl14993 Chemical compound CCCCOC1=CC=CC=C1C(NC1=O)=NC=C1C1=NN=NN1 ALXDNQNBMITZNJ-UHFFFAOYSA-N 0.000 description 1
- FXYFCHIWHHJQLC-UHFFFAOYSA-N chembl15044 Chemical compound CCC(C)OC1=CC=CC=C1C(N=C1O)=NC=C1C1=NNN=N1 FXYFCHIWHHJQLC-UHFFFAOYSA-N 0.000 description 1
- DPBCDZSNXSBXIH-UHFFFAOYSA-N chembl15205 Chemical class O=C1NC(C=2C=CC=CC=2)=NC=C1C1=NN=NN1 DPBCDZSNXSBXIH-UHFFFAOYSA-N 0.000 description 1
- XWPXWCKFSQPZAL-UHFFFAOYSA-N chembl15358 Chemical compound O=C1NC(C=2C(=CC=CC=2)OCC2CC2)=NC=C1C1=NN=NN1 XWPXWCKFSQPZAL-UHFFFAOYSA-N 0.000 description 1
- XLBJIHSODBALQX-UHFFFAOYSA-N chembl15378 Chemical compound CCCOC1=CC=C([N+]([O-])=O)C=C1C(NC1=O)=NC=C1C1=NN=NN1 XLBJIHSODBALQX-UHFFFAOYSA-N 0.000 description 1
- QPXUYQLYVJSOLC-UHFFFAOYSA-N chembl15390 Chemical compound CCCOC1=CC=C(OC)C=C1C(NC1=O)=NC=C1C1=NN=NN1 QPXUYQLYVJSOLC-UHFFFAOYSA-N 0.000 description 1
- IJOQOJJGZSTHEC-UHFFFAOYSA-N chembl15703 Chemical compound COC1=CC=CC=C1C(NC1=O)=NC=C1C1=NN=NN1 IJOQOJJGZSTHEC-UHFFFAOYSA-N 0.000 description 1
- BXQHTVRZNJXKFX-UHFFFAOYSA-N chembl276927 Chemical compound CC(C)OC1=CC=CC=C1C(NC1=O)=NC=C1C1=NN=NN1 BXQHTVRZNJXKFX-UHFFFAOYSA-N 0.000 description 1
- ZXWFWNPZBJUFHU-UHFFFAOYSA-N chembl277963 Chemical compound CCCOC1=CC=C(N)C=C1C(NC1=O)=NC=C1C1=NN=NN1 ZXWFWNPZBJUFHU-UHFFFAOYSA-N 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 150000003841 chloride salts Chemical class 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 125000004663 dialkyl amino group Chemical group 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical class OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- DENRZWYUOJLTMF-UHFFFAOYSA-N diethyl sulfate Chemical compound CCOS(=O)(=O)OCC DENRZWYUOJLTMF-UHFFFAOYSA-N 0.000 description 1
- 229940008406 diethyl sulfate Drugs 0.000 description 1
- 125000001664 diethylamino group Chemical group [H]C([H])([H])C([H])([H])N(*)C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 230000009429 distress Effects 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 229960005139 epinephrine Drugs 0.000 description 1
- QVVPWDIQTGSUOY-UHFFFAOYSA-N ethane-1,2-diamine;dihydrate Chemical compound O.O.NCCN QVVPWDIQTGSUOY-UHFFFAOYSA-N 0.000 description 1
- MFTDNOFYYUJVQN-UHFFFAOYSA-N ethyl 2-(2,4-dimethoxyphenyl)-6-oxo-1h-pyrimidine-5-carboxylate Chemical compound N1C(=O)C(C(=O)OCC)=CN=C1C1=CC=C(OC)C=C1OC MFTDNOFYYUJVQN-UHFFFAOYSA-N 0.000 description 1
- SGOISQDWJKLELV-UHFFFAOYSA-N ethyl 2-(2,5-dimethoxyphenyl)-6-oxo-1h-pyrimidine-5-carboxylate Chemical compound N1C(=O)C(C(=O)OCC)=CN=C1C1=CC(OC)=CC=C1OC SGOISQDWJKLELV-UHFFFAOYSA-N 0.000 description 1
- QCQYODARJSKOCU-UHFFFAOYSA-N ethyl 2-(2-butoxyphenyl)-6-oxo-1h-pyrimidine-5-carboxylate Chemical compound CCCCOC1=CC=CC=C1C1=NC=C(C(=O)OCC)C(=O)N1 QCQYODARJSKOCU-UHFFFAOYSA-N 0.000 description 1
- VAAXCOQPYJLRDA-UHFFFAOYSA-N ethyl 2-(2-chlorophenyl)-6-oxo-1h-pyrimidine-5-carboxylate Chemical compound N1C(=O)C(C(=O)OCC)=CN=C1C1=CC=CC=C1Cl VAAXCOQPYJLRDA-UHFFFAOYSA-N 0.000 description 1
- PCYYUCFZMOLLEK-UHFFFAOYSA-N ethyl 2-(2-ethoxy-5-ethoxycarbonylphenyl)-6-oxo-1h-pyrimidine-5-carboxylate Chemical compound CCOC(=O)C1=CC=C(OCC)C(C=2NC(=O)C(C(=O)OCC)=CN=2)=C1 PCYYUCFZMOLLEK-UHFFFAOYSA-N 0.000 description 1
- HHCBTMADUMSFOZ-UHFFFAOYSA-N ethyl 2-(2-ethoxy-5-nitrophenyl)-6-oxo-1h-pyrimidine-5-carboxylate Chemical compound N1C(=O)C(C(=O)OCC)=CN=C1C1=CC([N+]([O-])=O)=CC=C1OCC HHCBTMADUMSFOZ-UHFFFAOYSA-N 0.000 description 1
- NTWWWQBBFMYJLO-UHFFFAOYSA-N ethyl 2-(2-methoxyphenyl)-6-oxo-1h-pyrimidine-5-carboxylate Chemical compound N1C(=O)C(C(=O)OCC)=CN=C1C1=CC=CC=C1OC NTWWWQBBFMYJLO-UHFFFAOYSA-N 0.000 description 1
- SUJFHOCCPFSRSE-UHFFFAOYSA-N ethyl 2-(2-methylsulfanylphenyl)-6-oxo-1h-pyrimidine-5-carboxylate Chemical compound N1C(=O)C(C(=O)OCC)=CN=C1C1=CC=CC=C1SC SUJFHOCCPFSRSE-UHFFFAOYSA-N 0.000 description 1
- BCXUQKLCLIQWQM-UHFFFAOYSA-N ethyl 2-(2-nitrophenyl)-6-oxo-1h-pyrimidine-5-carboxylate Chemical compound N1C(=O)C(C(=O)OCC)=CN=C1C1=CC=CC=C1[N+]([O-])=O BCXUQKLCLIQWQM-UHFFFAOYSA-N 0.000 description 1
- YQBCAZKPSCFNCE-UHFFFAOYSA-N ethyl 2-(3-methoxyphenyl)-6-oxo-1h-pyrimidine-5-carboxylate Chemical compound N1C(=O)C(C(=O)OCC)=CN=C1C1=CC=CC(OC)=C1 YQBCAZKPSCFNCE-UHFFFAOYSA-N 0.000 description 1
- QRCGEXTZQXTKPB-UHFFFAOYSA-N ethyl 2-(4-chlorophenyl)-6-oxo-1h-pyrimidine-5-carboxylate Chemical compound N1C(=O)C(C(=O)OCC)=CN=C1C1=CC=C(Cl)C=C1 QRCGEXTZQXTKPB-UHFFFAOYSA-N 0.000 description 1
- SALSCUNMSHAFTO-UHFFFAOYSA-N ethyl 2-(4-methoxyphenyl)-6-oxo-1h-pyrimidine-5-carboxylate Chemical compound N1C(=O)C(C(=O)OCC)=CN=C1C1=CC=C(OC)C=C1 SALSCUNMSHAFTO-UHFFFAOYSA-N 0.000 description 1
- IKKKBBJLLAAYDF-UHFFFAOYSA-N ethyl 2-(5-amino-2-ethoxyphenyl)-6-oxo-1h-pyrimidine-5-carboxylate Chemical compound N1C(=O)C(C(=O)OCC)=CN=C1C1=CC(N)=CC=C1OCC IKKKBBJLLAAYDF-UHFFFAOYSA-N 0.000 description 1
- SNQYWDIUKAUIRL-UHFFFAOYSA-N ethyl 2-(5-chloro-2-ethoxyphenyl)-6-oxo-1h-pyrimidine-5-carboxylate Chemical compound N1C(=O)C(C(=O)OCC)=CN=C1C1=CC(Cl)=CC=C1OCC SNQYWDIUKAUIRL-UHFFFAOYSA-N 0.000 description 1
- UNFJAPCUHYWJOP-UHFFFAOYSA-N ethyl 2-ethoxybenzenecarboximidate;sulfurofluoridic acid Chemical compound OS(F)(=O)=O.CCOC(=N)C1=CC=CC=C1OCC UNFJAPCUHYWJOP-UHFFFAOYSA-N 0.000 description 1
- HJJTUMWNCSKZNW-UHFFFAOYSA-N ethyl 6-oxo-2-(2-propan-2-yloxyphenyl)-1h-pyrimidine-5-carboxylate Chemical compound N1C(=O)C(C(=O)OCC)=CN=C1C1=CC=CC=C1OC(C)C HJJTUMWNCSKZNW-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 239000008098 formaldehyde solution Substances 0.000 description 1
- 125000002541 furyl group Chemical group 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 229940047135 glycate Drugs 0.000 description 1
- 125000003707 hexyloxy group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])O* 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- JUINSXZKUKVTMD-UHFFFAOYSA-N hydrogen azide Chemical compound N=[N+]=[N-] JUINSXZKUKVTMD-UHFFFAOYSA-N 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 229940071870 hydroiodic acid Drugs 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 229940039009 isoproterenol Drugs 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 150000007517 lewis acids Chemical class 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000012669 liquid formulation Substances 0.000 description 1
- 239000012263 liquid product Substances 0.000 description 1
- GUWHRJQTTVADPB-UHFFFAOYSA-N lithium azide Chemical class [Li+].[N-]=[N+]=[N-] GUWHRJQTTVADPB-UHFFFAOYSA-N 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 description 1
- 239000000347 magnesium hydroxide Substances 0.000 description 1
- 229910001862 magnesium hydroxide Inorganic materials 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 229940049920 malate Drugs 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- VQGDVXIMWWGBNY-UHFFFAOYSA-N methyl 2-carbamimidoylbenzoate Chemical compound COC(=O)C1=CC=CC=C1C(N)=N VQGDVXIMWWGBNY-UHFFFAOYSA-N 0.000 description 1
- NZCNQOPLKTYKQB-UHFFFAOYSA-N methyl 2-ethoxy-5-methoxybenzenecarboximidate;sulfurofluoridic acid Chemical compound OS(F)(=O)=O.CCOC1=CC=C(OC)C=C1C(=N)OC NZCNQOPLKTYKQB-UHFFFAOYSA-N 0.000 description 1
- YXOZOCRLGICTPN-UHFFFAOYSA-N methyl 2-ethoxybenzenecarboximidate;methyl hydrogen sulfate Chemical compound COS(O)(=O)=O.CCOC1=CC=CC=C1C(=N)OC YXOZOCRLGICTPN-UHFFFAOYSA-N 0.000 description 1
- KBVGDNOKQIRHSD-UHFFFAOYSA-N methyl 3-carbamimidoyl-4-ethoxybenzoate Chemical compound C(=O)(OC)C=1C=CC(=C(C(=N)N)C1)OCC.C(=O)(OC)C=1C=CC(=C(C(=N)N)C1)OCC KBVGDNOKQIRHSD-UHFFFAOYSA-N 0.000 description 1
- WYTKHSAZZPUCPK-UHFFFAOYSA-N methyl 3-carbamimidoyl-4-ethoxybenzoate Chemical compound CCOC1=CC=C(C(=O)OC)C=C1C(N)=N WYTKHSAZZPUCPK-UHFFFAOYSA-N 0.000 description 1
- OHSWRVNWUHUSSN-UHFFFAOYSA-N methyl 3-carbamoyl-4-hydroxybenzoate Chemical compound COC(=O)C1=CC=C(O)C(C(N)=O)=C1 OHSWRVNWUHUSSN-UHFFFAOYSA-N 0.000 description 1
- BLHOGOSXQVNCCS-UHFFFAOYSA-N methyl 5-methoxy-2-propoxybenzenecarboximidate;sulfurofluoridic acid Chemical compound OS(F)(=O)=O.CCCOC1=CC=C(OC)C=C1C(=N)OC BLHOGOSXQVNCCS-UHFFFAOYSA-N 0.000 description 1
- FGFLVXMKWVVLRQ-UHFFFAOYSA-N methyl hydrogen sulfate;methyl 2-propoxybenzenecarboximidate Chemical compound COS(O)(=O)=O.CCCOC1=CC=CC=C1C(=N)OC FGFLVXMKWVVLRQ-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- IOQPZZOEVPZRBK-UHFFFAOYSA-N octan-1-amine Chemical compound CCCCCCCCN IOQPZZOEVPZRBK-UHFFFAOYSA-N 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 229960001412 pentobarbital Drugs 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 229940124531 pharmaceutical excipient Drugs 0.000 description 1
- 235000011007 phosphoric acid Nutrition 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- BDAWXSQJJCIFIK-UHFFFAOYSA-N potassium methoxide Chemical compound [K+].[O-]C BDAWXSQJJCIFIK-UHFFFAOYSA-N 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 125000006239 protecting group Chemical group 0.000 description 1
- 125000004076 pyridyl group Chemical group 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 150000003335 secondary amines Chemical class 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- WZODLFCLKIXWGA-UHFFFAOYSA-N sodium 4-amino-6-[[4-[4-[(8-amino-1-hydroxy-5,7-disulfonaphthalen-2-yl)diazenyl]-3-methylphenyl]-2-methylphenyl]diazenyl]-5-hydroxynaphthalene-1,3-disulfonic acid Chemical compound CC1=C(C=CC(=C1)C2=CC(=C(C=C2)N=NC3=C(C4=C(C=C3)C(=CC(=C4N)S(=O)(=O)O)S(=O)(=O)O)O)C)N=NC5=C(C6=C(C=C5)C(=CC(=C6N)S(=O)(=O)O)S(=O)(=O)O)O.[Na+] WZODLFCLKIXWGA-UHFFFAOYSA-N 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- BEOOHQFXGBMRKU-UHFFFAOYSA-N sodium cyanoborohydride Chemical compound [Na+].[B-]C#N BEOOHQFXGBMRKU-UHFFFAOYSA-N 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000013222 sprague-dawley male rat Methods 0.000 description 1
- 238000012453 sprague-dawley rat model Methods 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- 125000003831 tetrazolyl group Chemical group 0.000 description 1
- 229960000278 theophylline Drugs 0.000 description 1
- 125000001544 thienyl group Chemical group 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 238000009966 trimming Methods 0.000 description 1
- 229960004418 trolamine Drugs 0.000 description 1
- 229960001005 tuberculin Drugs 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
- C07D239/36—One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US65778776A | 1976-02-13 | 1976-02-13 | |
| US05/748,851 US4082751A (en) | 1976-02-13 | 1976-12-08 | Therapeutic agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS52118481A JPS52118481A (en) | 1977-10-04 |
| JPS6139947B2 true JPS6139947B2 (enrdf_load_stackoverflow) | 1986-09-06 |
Family
ID=27097492
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP1433577A Granted JPS52118481A (en) | 1976-02-13 | 1977-02-14 | Therapeutic agents |
Country Status (14)
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4419357A (en) * | 1982-01-18 | 1983-12-06 | The Dow Chemical Company | 3-(1H-Tetrazol-5-yl)-4(3H)-quinazolinones |
| CN101747282A (zh) * | 2008-12-10 | 2010-06-23 | 上海特化医药科技有限公司 | 一类含有嘧啶酮苯基的化合物、其药物组合物及其制备方法和用途 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3883653A (en) * | 1972-10-24 | 1975-05-13 | Pfizer | Method of preventing asthmatic symptoms |
-
1977
- 1977-02-03 AU AU21895/77A patent/AU508970B2/en not_active Expired
- 1977-02-08 LU LU76722A patent/LU76722A1/xx unknown
- 1977-02-09 FR FR7703650A patent/FR2340943A1/fr active Granted
- 1977-02-09 GB GB5437/77A patent/GB1541351A/en not_active Expired
- 1977-02-09 FI FI770427A patent/FI62533C/fi not_active IP Right Cessation
- 1977-02-09 CA CA271,406A patent/CA1083152A/en not_active Expired
- 1977-02-10 DE DE19772705609 patent/DE2705609A1/de active Granted
- 1977-02-10 DK DK57377A patent/DK149044C/da not_active IP Right Cessation
- 1977-02-11 YU YU354/77A patent/YU41567B/xx unknown
- 1977-02-11 CH CH173477A patent/CH635339A5/de not_active IP Right Cessation
- 1977-02-11 IE IE297/77A patent/IE44603B1/en unknown
- 1977-02-11 NL NLAANVRAGE7701483,A patent/NL173055C/xx not_active IP Right Cessation
- 1977-02-11 SE SE7701552A patent/SE433494B/xx not_active IP Right Cessation
- 1977-02-14 JP JP1433577A patent/JPS52118481A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| SE433494B (sv) | 1984-05-28 |
| FI62533C (fi) | 1983-01-10 |
| IE44603L (en) | 1977-08-13 |
| LU76722A1 (enrdf_load_stackoverflow) | 1977-08-18 |
| CA1083152A (en) | 1980-08-05 |
| GB1541351A (en) | 1979-02-28 |
| NL7701483A (nl) | 1977-08-16 |
| FR2340943B1 (enrdf_load_stackoverflow) | 1981-01-09 |
| DE2705609A1 (de) | 1977-08-25 |
| AU508970B2 (en) | 1980-04-17 |
| NL173055B (nl) | 1983-07-01 |
| DK149044C (da) | 1986-06-02 |
| CH635339A5 (en) | 1983-03-31 |
| DE2705609C2 (enrdf_load_stackoverflow) | 1988-12-15 |
| FR2340943A1 (fr) | 1977-09-09 |
| SE7701552L (sv) | 1977-09-23 |
| YU35477A (en) | 1982-10-31 |
| DK57377A (da) | 1977-08-14 |
| JPS52118481A (en) | 1977-10-04 |
| IE44603B1 (en) | 1982-01-27 |
| YU41567B (en) | 1987-10-31 |
| NL173055C (nl) | 1983-12-01 |
| AU2189577A (en) | 1978-08-10 |
| FI62533B (fi) | 1982-09-30 |
| DK149044B (da) | 1985-12-30 |
| FI770427A7 (enrdf_load_stackoverflow) | 1977-08-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5118686A (en) | Phenylpyrimidones | |
| CA1098520A (en) | Optionally substituted 3-(1h-tetrazol-5-yl)-4h- pyrido¬1,2-a| pyrimidin-4-ones | |
| US8183253B2 (en) | Phenylaminopyrimidine derivatives as inhibitors of bcr-abl kinase | |
| JP2002520395A (ja) | キノリン誘導体 | |
| NZ251804A (en) | Aromatic quinazoline derivatives and medicaments | |
| US20200031844A1 (en) | Tetrahydrothiopyranopyrimidine derivatives as anti-HIV agent | |
| CN106831605A (zh) | 一种取代二芳基嘧啶类衍生物及其制备方法与应用 | |
| US4082751A (en) | Therapeutic agents | |
| JPS6222771A (ja) | ５−置換−６−アミノピリミジン誘導体、組成物および使用 | |
| JPS6139947B2 (enrdf_load_stackoverflow) | ||
| JPS60502003A (ja) | 強心剤として有効な〔（ピリジニル）−２−ピリミジニル〕尿素及び同化合物を含む製剤 | |
| KR900003649B1 (ko) | (1H-테트라졸-5-일)테트라졸로[1,5-a]-퀴놀린의 제조방법 | |
| US5290933A (en) | Phenylpyrimidone derivatives | |
| CA1117112A (en) | Pyrido¬1,2-a|pyrimidine-3-n-(1h-tetrazol-5-yl| carboxamide derivatives | |
| JP2930539B2 (ja) | トリフルオロメチルキノリンカルボン酸誘導体 | |
| NZ287550A (en) | 8-trifluoromethylquinolinecarboxylic acid derivatives; medicaments | |
| US3968213A (en) | Method of preventing asthmatic symptoms | |
| US3927214A (en) | Method of preventing asthmatic symptoms | |
| JPH0450310B2 (enrdf_load_stackoverflow) | ||
| US3957784A (en) | Bis(4-[4'-hydroxy-5'-carboxy-2'-pyrimidinyl]phenoxy)alkanes | |
| SE414175B (sv) | Analogiflrfarande for framstellning av anti-allergiska n-(-tetranzolyl)-pyrimido (1,2-a) kinolin-2-karboxamider | |
| JP2514812B2 (ja) | ３−（１Ｈ−テトラゾ−ル−５− イル） チエノ〔２，３−ｄ〕 ピリミジン−４（３Ｈ）−オン類 | |
| Kodonidi et al. | Optimized Synthesis of the O-Benzoylaminobenzoic Acid Derivative 2-Benzoylamino-N-[4-(4, 6-Dimethylpyrimidin-2-Ylsulfamoyl) Phenyl] Benzamide Possessing Anxiolytic Activity | |
| US3917835A (en) | A method of preventing asthmatic symptoms | |
| US3927215A (en) | Method of preventing asthmatic symptoms |